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INTRODUCTION
Brunner’s gland, which was accurately described by Brun-
ner in 1688, is a gland in the submucosa of the duodenum
(1), which has a main physiological function of secreting an
alkaline-based mucus to protect the duodenal lining from
the acid secreted in the stomach. Brunner’s gland hyperpla-
sia makes up 10.6% of benign tumors in the duodenum and
rarely presents any symptoms (2). The first case of Brunner’s
gland hyperplasia was reported in 1835 in a patient with
fatal duodenal intussusceptions (3). It is usually found inci-
dentally because it is small and asymptomatic. However,
Brunner’s gland hyperplasia can lead to significant symptoms
including gastrointestinal bleeding, abdominal pain, and
intestinal obstruction. The Brunner’s gland hyperplasia is
generally polypoid in configuration. We report on an unusu-
al case of a diffuse nodular type of Brunner’s gland hyper-
plasia with symptoms of intermittent upper abdominal pain,
nausea, and vomiting, which was difficult to differentiate from
malignancy.
CASE REPORT
A 64-yr-old man visited a private clinic with episodes of
epigastric discomfort, dyspepsia, nausea, and vomiting for
several days. A duodenal mass was found on esophagogas-
troduodenoscopy. He was then referred to our hospital. On
admission, he had no significant past medical history, but
had a weight loss of 7 kg. Laboratory values were as follows:
white blood cells 10,950/μ L, hemoglobin 12.9 g/dL, platelets
295 K/μ L, aspartate aminotransferases (AST) 25 IU/mL, ala-
nine aminotransferases (ALT) 10 IU/mL, alkaline phosphatase
(ALP) 72 IU/L, gamma glutamyl transpeptidase (gamma-
GT) 102 IU/L, and total bilirubin 0.7 mg/dL. Other labo-
ratory values were within normal limits. An esophagogas-
troduodenoscopy showed an infiltrating type mass on the
second portion of the duodenum with luminal narrowing.
So, the scope could not pass through the narrowed lumen
(Fig. 1). A 3-D abdominal computer tomography (CT) was
then performed, which showed a 2.5 cm-sized mass in the
second portion of duodenum and a loss of fat plane between
the duodenal mass and pancreas, which gave suspicion of a
pancreatic invasion and a 7 mm-sized lymph node around
the duodenum. The stage based on the CT finding was stage
III (T3, N1, Mx) (Fig. 2). The tissue from the endoscopic
biopsy showed moderate and chronically active duodenitis.
Since the patient had symptoms of recurrent vomiting and
weight loss due to duodenal obstruction and the finding
from the abdominal CT was suspicious of duodenal cancer
in the second portion with a pancreatic invasion, we decid-
ed to perform an operation on the patient. The frozen biop-
sy from the operation showed a pancreatic heterotopia with-
out evidence of malignancy. However, we performed a duo-
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Brunner’ s Gland Hyperplasia: Treatment of Severe Diffuse Nodular
Hyperplasia Mimicking a Malignancy on Pancreatic-Duodenal Area  
Brunner’s gland hyperplasia is a benign tumor of the duodenum and it is rarely
associated with clinical symptoms. We report on a 64-yr-old man with Brunner’s
gland hyperplasia who had undergone a duodenocephalo-pancreatectomy. The
reason is that he presented upper gastrointestinal obstructive symptoms and the
esophagogastroduodenoscopic finding revealed the lesion to be an infiltrating type
mass on the second portion of the duodenum with luminal narrowing. An abdomi-
nal computed tomography showed a 2.5 cm-sized mass in the duodenal second
portion with a suspicious pancreatic invasion and 7 mm-sized lymph node around
the duodenum. Duodenocephalopancreatectomy was successfully performed. His-
tological examination revealed a Brunner’s gland hyperplasia. The final diagnosis
was the coexistence of Brunner’s gland hyperplasia and pancreatic heterotopia with
a pancreatic head invasion. The literature on Brunner’s gland hyperplasia is reviewed.
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denocephalopancreatectomy, because we could not com-
pletely exclude malignancy due to the CT finding and sus-
pected that the lesion leading to duodenal obstruction in
the second portion of duodenum included the ampulla. 
The histological examination of the second portion of the
duodenum showed a diffuse nodular type of Brunner’s glands
hyperplasia with inflammation of the ampulla, and there was
reactive lymphadenopathy of regional lymph nodes. Pancre-
atic heterotopia was found in the subserosa of the duodenum
(Fig. 3). Finally, the patient was diagnosed with a diffuse
nodular type of Brunner’s gland hyperplasia with duodenal
obstruction. The patient was discharged 25 days after the
operation without any complications.
DISCUSSION 
Patients who have Brunner’s gland hyperplasia of the duo-
denum are frequently affected with chronic pancreatitis (4),
duodenal ulcers, and chronic erosive gastritis. The cause of
Brunner’s gland hyperplasia is thought to be chronic inflam-
mation, chronic stimulus by excessive secretion of gastric
acids, or the decrease of the pancreatic exocrine function.
However, it is recently thought that the hyperactivity of the
exocrine modulating factor (hormone, vagus nerve, and intesti-
nal mucous membrane factor) is the major cause of Brunner’s
gland hyperplasia (5).
The clinical manifestations of Brunner’s gland hyperpla-
sia are nonspecific, such as epigastric discomfort , abdomi-
nal distension, or dyspepsia etc. Occasionally, it can lead to
hemorrhages, acceleration of peristalsis, diarrhea, transient
and partial bowel obstruction and duodenal intussusception
due to the mass (3).
Brunner’s gland hyperplasia, a submucosal tumor, can be
diagnosed by endoscopy, biopsy, abdominal CT, and other
radiologic techniques. Only about 0.3-4.6% of the benign
tumor originating from the duodenum can be found by the
endoscope (6). Brunner’s gland hyperplasia is vary rare and
Fig. 1. Endoscopic finding: the duodenal mass was an irregular
and infiltrative type mass on the duodenal bulb area.
Fig. 2. Abdominal computed tomography: (A) obstruction finding
due to circumference of the duodenal mass (B) lymph node en-
largement circumference of the duodenal mass (C) pancreatic
invasion with fat tissue loss between the duodenal mass and pan-
creatic head.
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Fig. 3. Biopsy: (A) (×10) Brunner’s gland hyperplasia, diffuse infil-
trated type (B) (×100) Brunner’s gland hyperplasia (C) (×400)
pancreatic heterotopia in the serosa layer. 
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represents 10.6% among this amount (7). 
Brunner’s gland hyperplasia is distributed mainly on the
duodenal bulb (57%), the duodenum’s second portion (27%),
and its third portion (7%). It is rarely on the pylorus (5%),
jejunum (2%), or the terminal ileum (2%) (8). 
In 1934, Feyrter classified the abnormal glandular prolif-
eration into the following three types: diffuse nodular hyper-
plasia (type 1), occupying most of the duodenum; circum-
script nodular hyperplasia (type 2), the most common type
mainly present in the duodenal bulb; and, adenomatous
hyperplasia (type 3), which may be sessile or pedunculated
(4, 9-12). 
This first-mentioned type corresponds with the Brunner’s
gland hyperplasia found in our patient. This diffuse nodular
hyperplasia (type 1) is often mistaken for a malignancy. 
The diagnosis of Brunner’s gland hyperplasia is supported
by endoscopy and radiologic findings. However, sensitivity
of the endoscopy is 72-89% and occasionally, the endoscopy
is not useful in making the diagnosis (3, 7, 13, 14). Thus,
we found that abdominal CT was useful in this case.
There is no consensus on the therapeutic principle for Brun-
ner’s gland hyperplasia because follow-up study is insuffi-
cient. The medical treatment is to control gastric hyperacid-
ity, which is one cause of Brunner’s gland hyperplasia. How-
ever, the regression of Brunner’s gland hyperplasia is rare (7).
Therefore, excision appears to be the treatment of choice.
We should completely remove the lesion by endoscopic resec-
tion or surgical resection when Brunner’s gland hyperplasia
leads to symptoms and complications or when definite diag-
nosis is necessary (7, 15-17). 
According to a recent report, other research opinions state
that non-symptomatic Brunner’s gland hyperplasia should
be resected by all means because it undergoes malignant trans-
formations in some cases (7, 18). 
There are various methods for the resection of Brunner’s
gland hyperplasia. For instance, endoscopic polypectomy
should be performed if the lesions are less than 1 cm in diam-
eter, if the size is excessively large or if the tumor is the ses-
sile type. Then, surgical polypectomy, duodenal wedge resec-
tion, or partial gastrectomy that is extended to the duodenal
bulb should be done (7). However, there is one report of a
duodenocephalopancreatectomy, in a Brunner’s gland hyper-
plasia case involving the duodenal second portion with a
pancreatic invasion (7). Domenico Lusco et al. reported the
case of a voluminous Brunner’s gland hyperplasia induced
stenosis of the duodenal second portion and a pancreatic duct
dilatation on an abdominal CT finding. Even though the
frozen biopsy showed no evidence of malignancy, they decid-
ed to carry on with the operation because they could not ex-
clude the possibility of malignancy (7).
Our case is similar to the case by Domenico Lusco et al.
The abdominal CT scans of this case showed the findings of
duodenal cancer with a pancreatic head invasion and a region-
al lymph node enlargement. Also, the patient had symptoms
of nausea, vomiting, and epigastric pain due to obstruction.
This case helped us to decide on the operation. The histo-
logical findings of frozen biopsy from the operation had no
evidence of malignancy, but showed pancreatic heterotopia.
However, sensitivity of frozen biopsy is 83-92% (19-22) and
its diagnostic accuracy is 91-97% (19, 23, 24). So, we could
not exclude malignancy even after a frozen biopsy. The exci-
sion area should be minimal in Brunner’s gland hyperplasia
because it is a benign tumor. However, if the tumor involves
the second portion of duodenum and invades the pancreatic
area just as in this case, then duodenocephalopancreatecto-
my should be considered.
Another unique aspect of this case is the coexistence of
Brunner’s gland hyperplasia and pancreatic heterotophia.
The relation of ectopic pancreas and Brunner’s gland hyper-
plasia is not clear. Although there is less connection between
the cause of Brunner’s gland hyperplasia and the pancreatic
heterotophia, we need further studies about the relationship
of Brunner’s gland hyperplasia with pancreatic hetero-
tophia. 
In our case, a duodenocephalopancreatectomy was per-
formed due to symptoms of Brunner’s gland hyperplasia
with a pancreatic invasion, which induced epigastric dis-
comfort, nausea, and vomiting.
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